ArticleInternational medical case reports journal2025
Treating Multiline Treatment Failure in Advanced Colon Cancer Based on Evolutionary Theory: A Case Report.
Article in International medical case reports journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Currently, there is no standard regimen for third-line therapy in advanced colon cancer. Intratumoral heterogeneity and tumor evolution have been substantiated in multiple cancer types, paving the way for exploratory research into new treatment strategies for pulmonary metastases from colorectal cancer. Patients and Methods: In this report, we present a case of advanced colon cancer with lung metastasis. After multiple lines of therapy (including FOLFOX, FOLFIRI combined with targeted therapy) failed, the patient received a lung cancer-derived regimen to colorectal pulmonary metastases through an evolutionary perspective. Results: After two cycles, the patient achieved partial response (PR), and after eight cycles, the disease was stable (SD), with a good quality of life. Conclusion: The application of a lung cancer-derived regimen to colorectal pulmonary metastases through an evolutionary perspective may offer a new therapeutic direction for patients who have exhausted standard options.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.